Exact claim · Version 1 · Reviewed 2026-07-24
“Retatrutide is FDA-approved.”
A verdict on this wording and scope, not a universal grade for Retatrutide.
01 · Verdict
Misleading
It remains investigational. Positive trial results and sponsor announcements are not FDA marketing approval.
- Evidence basis
- Regulatory or product record
- Scope
- United States regulatory status as reviewed July 24, 2026.
- Category
- Approval and status
02 · Primary record
Check the attached evidence
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.